Sandoz

This study tested a new, potentially lower-cost version (biosimilar) of an existing melanoma drug called nivolumab (Opdivo). It compared how the body processes the drugs, their effectiveness, and safety when combined with another drug (ipilimumab/Yervoy) in adults with advanced s…